We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-0.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$52B
AUM Growth
-$1.61B
(-3%)
Cap. Flow
-$421M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
764
New
196
Increased
225
Reduced
259
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$109M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$92.2M |
| 3 |
Corning
GLW
|
+$81.5M |
| 4 |
IQVIA
IQV
|
+$62.7M |
| 5 |
Casella Waste Systems
CWST
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$715M |
| 2 |
Starbucks
SBUX
|
+$159M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$97.2M |
| 4 |
American Express
AXP
|
+$92.9M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
+$53.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.2% |
| 2 | Consumer Discretionary | 17.52% |
| 3 | Financials | 11.75% |
| 4 | Communication Services | 11.63% |
| 5 | Healthcare | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
NMI Holdings
NMIH
$3.36B
| $26.7M | 0.05% |
1,016,145
+115,328
| +13% | +$3.15M |
|
152
Post Holdings
POST
$3.57B
| $26.6M | 0.05% |
383,913
-468
| -0.1% | -$31.9K |
|
153
Popular Inc
BPOP
$11.1B
| $26.6M | 0.05% |
490,978
-815
| -0.2% | -$44.2K |
|
154
Prosperity Bancshares
PB
$8.89B
| $26.6M | 0.05% |
375,912
-702
| -0.2% | -$47.2K |
|
155
Armstrong World Industries
AWI
$7.84B
| $25.9M | 0.05% |
267,715
-481
| -0.2% | -$46.3K |
|
156
Globant
GLOB
$1.61B
| $25.7M | 0.05% |
281,014
+31,845
| +13% | +$3.16M |
|
|
MIME
157
DELISTED
Mimecast Limited
MIME
| $25.5M | 0.05% |
715,294
+81,121
| +13% | +$3.53M |
|
158
Bright Horizons
BFAM
$3.86B
| $25.2M | 0.05% |
165,387
-178,294
| -52% | -$27.9M |
|
159
Guidewire Software
GWRE
$14.2B
| $25.2M | 0.05% |
238,675
-253,210
| -51% | -$25.5M |
|
160
Home BancShares
HOMB
$6.18B
| $25M | 0.05% |
1,332,363
-1,656
| -0.1% | -$31K |
|
|
IAA
161
DELISTED
IAA, Inc. Common Stock
IAA
| $25M | 0.05% |
597,937
-219,591
| -27% | -$9.89M |
|
162
Arcosa
ACA
$7.11B
| $24.8M | 0.05% |
724,339
-1,031
| -0.1% | -$35.7K |
|
163
AMN Healthcare
AMN
$1.4B
| $24.5M | 0.05% |
425,340
-488
| -0.1% | -$27K |
|
164
Rogers Corp
ROG
$2.4B
| $24.4M | 0.05% |
178,126
+37,306
| +26% | +$5.5M |
|
165
AtriCure
ATRC
$2.11B
| $24.3M | 0.05% |
973,209
+48,336
| +5% | +$1.38M |
|
|
ALE
166
DELISTED
Allete
ALE
| $23.9M | 0.05% |
273,496
-715
| -0.3% | -$61.5K |
|
167
Steven Madden
SHOO
$3.55B
| $23.8M | 0.05% |
664,252
-80,278
| -11% | -$2.65M |
|
168
Evertec
EVTC
$1.78B
| $23.6M | 0.05% |
756,920
+85,855
| +13% | +$2.88M |
|
|
GHDX
169
DELISTED
Genomic Health, Inc.
GHDX
| $23.5M | 0.05% |
345,813
-53,669
| -13% | -$3.69M |
|
|
XIFR
170
XPLR Infrastructure LP
XIFR
$1.08B
| $23.3M | 0.04% |
441,462
-839
| -0.2% | -$42.2K |
|
171
HEICO Corp
HEI
$51.4B
| $23.1M | 0.04% |
184,900
+3,943
| +2% | +$539K |
|
|
EFOR
172
Everforth Inc
EFOR
$1.32B
| $22.9M | 0.04% |
364,061
-590
| -0.2% | -$36.4K |
|
|
PRSU
173
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $22.5M | 0.04% |
335,633
-8,452
| -2% | -$569K |
|
174
El Paso Energy Capital Trust I
EP.PRC
$223M
| $22.4M | 0.04% |
1,089,191
-13,058
| -1% | -$678K |
|
|
SBNY
175
DELISTED
Signature Bank
SBNY
| $22.4M | 0.04% |
188,130
+462
| +0.2% | +$55.9K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2019 Portfolio in Review
As of Q3 2019, Loomis, Sayles & Company held 764 positions worth $52B, down 3% from $53.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q3 2019 filing shows 196 new, 225 increased, 259 reduced and 63 closed positions. Its largest new stake was IQVIA: 402,725 shares worth $60.2M. The largest sale was Bank of America Series L, an estimated $715M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q3 2019 buy was IQVIA: 402,725 shares worth $60.2M.
- Loomis, Sayles & Company added most to Monster Beverage in Q3 2019, an estimated $109M increase.
- Loomis, Sayles & Company's biggest Q3 2019 reduction was Bank of America Series L, cutting an estimated $715M.
- Loomis, Sayles & Company fully exited Wright Medical Group Inc in Q3 2019, selling an estimated $53.7M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $52B portfolio in Q3 2019.
- Loomis, Sayles & Company opened 196 new positions and closed 63 in Q3 2019.
- Loomis, Sayles & Company's portfolio value fell 3% quarter-over-quarter to $52B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2019, filed 13 Nov 2019.